CXL plus PRK safe and effective at 10 years

CXL plus PRK safe and effective at 10 years
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Friday, February 15, 2019
Anastasios John Kanellopoulos MD The Athens Protocol for treating progressive keratoconus with photorefractive keratotomy and corneal cross-linking appears to be safe and effective, with little change after the first year in the majority of cases, although in some cases there is a progressive flattening in some corneas, said Anastasios John Kanellopoulos MD, New York University School of Medicine, New York, New York, USA. At the 23rd ESCRS Meeting in Athens, Greece, Dr Kannelopoulos presented an observational case series of 144 eyes treated for progressive keratoconus with the Athens Protocol procedure. All underwent preoperative and postoperative examination an average of 10 years after treatment The study showed that Snellen uncorrected distance visual acuity (UDVA) improved at one-year follow-up from 0.19 preoperatively to 0.53 and by 10 years improved further to 0.55±0.19. In addition, corrected distance visual acuity increased from 0.59 to 0.80 at one year, remaining stable at 10 years at 0.81. In addition, mean minimal corneal thickness decreased from 468.74 microns preoperatively to 391 microns at one year, but by 10 years had increased to 395.42 microns. Dr Kannelopoulos noted that 136 eyes showed no further keratoconic progression, although corneal topography showed progression in three eyes and five eyes had a hyperopic shift during the 10-year follow-up.
Tags: corneal crosslinking
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...